Abstract

Patients with neurodevelopmental disorders (NDDs) (ie, developmental delay, ASD, early-onset psychiatric or seizure disorders) increasingly seek evaluation of new or exacerbated symptoms concerning for autoimmune encephalitis (AE). AE diagnosis includes: 1) the presence of ≥2 of 7 neuropsychiatric domains over <3 months; 2) ≥1 objective finding of neuroinflammation; and 3) reasonable exclusion of alternative illnesses, which can be challenging in NDD patients due to symptom overlap between antineuronal autoimmunity and baseline atypical neurodevelopment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call